C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/02/2006	US20060246095 Multiepitope polypeptides for cancer immunotherapy
11/02/2006	US20060246092 Immunoprotective influenza antigen and its use in vaccination
11/02/2006	US20060246091 Avidin-pseudotyped viral vectors and their use
11/02/2006	US20060246090 Vaccine against hcv
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246078 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246067 Immunomodulatory constructs and their uses
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246059 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility
11/02/2006	US20060246058 Single-domain antigen-binding antibody fragments derived from llama antibodies
11/02/2006	US20060246046 Modified tridegins, production and use thereof as transglutaminase inihibitors
11/02/2006	US20060246044 Using electrical pulses and embryonic stem cell grafting to enhance cardiac tissue repair and nervous system regeneration; tissue engineering and repair; regenerative medicine
11/02/2006	US20060246042 Cells, culture methods, and their use in autologous transplantation therapy
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246032 Chimeric IL-10
11/02/2006	US20060246024 Method for stimulating hair follicle cell proliferation
11/02/2006	EP1717587A1 Method and kit for identifying the function of gene product and identifying binding substance
11/02/2006	EP1717323A2 Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method
11/02/2006	EP1717322A2 Evolution of whole cells and organisms by recursive sequence recombination
11/02/2006	EP1717317A1 Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter
11/02/2006	EP1717316A1 Interferon-like protein ZCYTO21
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717314A1 Receptor for modified low-density lipoprotein
11/02/2006	EP1717313A1 Nucleic acid probe, nucleic acid chip, method of detecting target nucleic acid, method of screening drug, apparatus for detecting target nucleic acid and gene diagnosis method
11/02/2006	EP1717312A1 Dna array for analyzing dna methylation, method of constructing the same and mehtod of analyzing dna methylaion
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717250A1 Monoclonal antibody and use thereof
11/02/2006	EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses
11/02/2006	EP1717248A1 Tumor targeted vector
11/02/2006	EP1717246A1 Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
11/02/2006	EP1717245A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1716869A1 Drug for preventing or treating heart diseases comprising cd9 gene
11/02/2006	EP1716862A1 Bactericide against streptococcus mutans and streptococcus sobrinus
11/02/2006	EP1716858A2 Oncolytic virus
11/02/2006	EP1716752A1 MyoD88-knockout mouse as a model animal unresponsive to bacterial cell wall components
11/02/2006	EP1716256A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
11/02/2006	EP1716243A1 Process for large scale production of plasmid dna by e coli fermentation
11/02/2006	EP1716241A1 Method for producing l-amino acids from d-amino acids
11/02/2006	EP1716239A2 Methods for enhancing insect resistance in plants
11/02/2006	EP1716238A1 Method for modifying gene expression of a phytopathogenic fungus
11/02/2006	EP1716237A1 Orotate transporter encoding marker genes
11/02/2006	EP1716236A2 Antisense oligonucleotides for treating unwanted pigmentation of the skin and hair
11/02/2006	EP1716235A2 Inhibitors of tgf-r signaling for treatment of cns disorders
11/02/2006	EP1716234A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals
11/02/2006	EP1716233A1 Regulated stop codon readthrough
11/02/2006	EP1716232A2 Acid alpha-glucosidase and fragments thereof
11/02/2006	EP1716231A1 Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof
11/02/2006	EP1716230A2 Lipases and methods of use
11/02/2006	EP1716229A2 Desaturase enzymes
11/02/2006	EP1716227A2 Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
11/02/2006	EP1716181A2 Cdr-repaired antibodies
11/02/2006	EP1716179A2 Monoclonal antibodies that specifically bind to folate receptor alpha
11/02/2006	EP1716177A1 Cytochrome c protein and assay
11/02/2006	EP1716175A2 Protein ligands for nkg2d and ul16 receptors and uses thereof
11/02/2006	EP1716173A2 Carcinoembryonic antigen fusion protein and uses thereof
11/02/2006	EP1716170A2 Hyphal growth in fungi
11/02/2006	EP1716165A2 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans - splicing
11/02/2006	EP1716164A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
11/02/2006	EP1715971A1 Functionalized colloidal metal compositions and methods
11/02/2006	EP1715896A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer
11/02/2006	EP1715745A2 Peptides for inhibiting insects
11/02/2006	EP1715736A2 Polypeptides having xylanase activity and polynucleotides encoding same
11/02/2006	EP1639110A4 Ryegrass pollen-specific promoters and expression constructs
11/02/2006	EP1608766A4 Glucosidases, nucleic acids encoding them and methods for making and using them
11/02/2006	EP1412758B1 Protein arrays, methods for their preparation and methods for the detection of intermolecular interactions
11/02/2006	EP1399551B1 Method for separating bacterial cells and cell components
11/02/2006	EP1317539B1 Directed evolution method
11/02/2006	EP1261629B1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
11/02/2006	EP1208192B1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers
11/02/2006	EP1144005B1 Treatment of papillomavirus infections
11/02/2006	EP1127130B1 Murine expression of human immunoglobulin lambda locus
11/02/2006	EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
11/02/2006	EP1105525B1 A process for preparing peptide nucleic acid probe using polymeric photoacid generator
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1019543B1 Method for identifying a nucleic acid
11/02/2006	EP1017822B1 Lkta deletion mutant of p. haemolytica
11/02/2006	EP1009834B1 Regulation of protein secretion
11/02/2006	EP1006785B1 Antimicrobial proteins
11/02/2006	EP1003874B1 Neisseria lactoferrin binding protein
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	EP0784695B1 Method for preparing nucleic acids for analysis and kits useful therefor
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	DE102005019967A1 Microbial production of L-amino acids, useful, e.g. as animal feed additives, using strains in which alanine-transaminase activity, or alanine production, is reduced or switched off
11/02/2006	DE102005016980A1 Isoliertes Photoprotein gr-Bolinopsin, sowie dessen Verwendung The isolated photoprotein gr-Bolinopsin, and its use
11/02/2006	CA2763805A1 P-cadherin antibodies
11/02/2006	CA2763671A1 P-cadherin antibodies
11/02/2006	CA2642861A1 Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with diseases caused by necrotrophic fungal pathogens
11/02/2006	CA2609788A1 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
11/02/2006	CA2607455A1 Antibodies with immune effector activity and that internalize in endosialin-positive cells
11/02/2006	CA2607444A1 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
11/02/2006	CA2606475A1 Polypeptides having endoglucanase activity and polynucleotides encoding same
11/02/2006	CA2606429A1 Materials and methods for respiratory disease control in canines
11/02/2006	CA2606088A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	CA2606083A1 Method for evaluating compound using barlp and substance for regulating eating and body weight
11/02/2006	CA2606002A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns
11/02/2006	CA2605782A1 Arabinofuranosidases
11/02/2006	CA2605697A1 Method of producing human igg antibodies with enhanced effector functions
11/02/2006	CA2605149A1 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein

1 ... 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 ... 4023